[The use of erythropoietin in HIV myelodysplasias. Preliminary study].
The authors gave recombinant human erythropoietin to four anaemic patients with HIV-infection treated with zidovudine. After erythropoietin administration an increase in haemoglobin, erythrocytes and haematocrit was observed and patients could continue AZT therapy.
USL n. 76, Ospedale Santo Spirito, Casale Monferrato.
L
L
Fruttaldo
G
G
Gatti
V
V
Deambrogio
F
F
Mongiò
G
G
Schettino
G
G
Cavagnolo
D000328:Adult; D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin; D015215:Zidovudine
Uso dell'eritropoietina nelle mielodisplasie da HIV. Studio preliminare.